title: Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma.
authors.forename: Stephanie J
authors.initials: SJ
authors.lastname: Carter
authors.forename: Steven H
authors.initials: SH
authors.lastname: Bernstein
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Friedberg
authors.forename: Paul M
authors.initials: PM
authors.lastname: Barr
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D000069461:Bendamustine Hydrochloride; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage; D045363:Pneumocystis carinii / Q000302:isolation & purification*; D011020:Pneumonia, Pneumocystis / Q000139:chemically induced* / Q000628:therapy; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D009588:Nitrogen Mustard Compounds; D000069283:Rituximab; D000069461:Bendamustine Hydrochloride